These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29500651)

  • 1. Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging.
    Lyu HL; Cao JX; Wang HY; Wang ZB; Hu MG; Ma L; Wang YW; Ye HY
    Abdom Radiol (NY); 2018 Oct; 43(10):2712-2720. PubMed ID: 29500651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-echo gradient chemical shift MR imaging fails to differentiate minimal fat renal angiomyolipomas from other homogeneous solid renal tumors.
    Ferré R; Cornelis F; Verkarre V; Eiss D; Correas JM; Grenier N; Hélénon O
    Eur J Radiol; 2015 Mar; 84(3):360-365. PubMed ID: 25547327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging.
    Kim JK; Kim SH; Jang YJ; Ahn H; Kim CS; Park H; Lee JW; Kim S; Cho KS
    Radiology; 2006 Apr; 239(1):174-80. PubMed ID: 16507752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
    Woo S; Cho JY; Kim SY; Kim SH
    Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
    Sasiwimonphan K; Takahashi N; Leibovich BC; Carter RE; Atwell TD; Kawashima A
    Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?
    Hindman N; Ngo L; Genega EM; Melamed J; Wei J; Braza JM; Rofsky NM; Pedrosa I
    Radiology; 2012 Nov; 265(2):468-77. PubMed ID: 23012463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade.
    Kim JH; Eun HW; Kim YJ; Han JK; Choi BI
    Abdom Imaging; 2013 Oct; 38(5):1106-14. PubMed ID: 23728305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.
    van der Pol CB; Lee S; Tsai S; Larocque N; Alayed A; Williams P; Schieda N
    Abdom Radiol (NY); 2019 Mar; 44(3):992-999. PubMed ID: 30603880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple pancreatic metastases from clear cell renal carcinoma: diagnosis with chemical shift magnetic resonance imaging before surgery.
    Koyama H; Maruta T; Kudo T; Mayahara H; Yoshida K
    Australas Radiol; 2005 Dec; 49(6):493-6. PubMed ID: 16351615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of rebound and lymphoid thymic hyperplasia from anterior mediastinal tumors with dual-echo chemical-shift MR imaging in adulthood: reliability of the chemical-shift ratio and signal intensity index.
    Priola AM; Priola SM; Ciccone G; Evangelista A; Cataldi A; Gned D; Pazè F; Ducco L; Moretti F; Brundu M; Veltri A
    Radiology; 2015 Jan; 274(1):238-49. PubMed ID: 25105246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between fat-poor angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    Ye J; Xu Q; Wang SA; Zheng J; Zhu QQ; Dou WQ
    Abdom Radiol (NY); 2020 Feb; 45(2):512-519. PubMed ID: 31705246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Li J; Liang L; Yu H; Shen Y; Hu Y; Hu D; Tang H; Li Z
    Magn Reson Imaging; 2019 Jan; 55():52-59. PubMed ID: 30240758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
    Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
    J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative diagnostic performance of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for differentiating clear cell and non-clear cell renal cell carcinoma.
    Zhao P; Zhu J; Wang L; Li N; Zhang X; Li J; Luo Y; Li Q
    Eur Radiol; 2023 May; 33(5):3766-3774. PubMed ID: 36725722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.
    Kang TW; Kim SH; Lee J; Kim AY; Jang KM; Choi D; Kim MJ
    Eur J Radiol; 2015 Nov; 84(11):2089-96. PubMed ID: 26318820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.
    Xiao B; Jiang ZQ; Hu JX; Zhang XM; Xu HB
    Medicine (Baltimore); 2019 Aug; 98(35):e16960. PubMed ID: 31464937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
    AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Angiomyolipoma With Minimal Fat from Clear Cell Renal Cell Carcinoma Using Non-contrast Multiparametric Magnetic Resonance Imaging.
    Jomoto W; Takaki H; Yamamoto S; Kanematsu A; Igeta M; Hirota S; Yamakado K
    In Vivo; 2022; 36(6):2790-2799. PubMed ID: 36309367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.